Myeloperoxidase, in the presence of noncytotoxic concentrations of H202, was used to induce cytotoxicity to the lung epithelial cell line, AKD. When the cationic aminoglycosides, tobramycin and gentamicin were added to the cells in the presence of myeloperoxidase and H202, cytotoxicity was completely inhibited. In addition, tobramycin prevented cytotoxicity induced by cystic fibrosis sputum and H202. Protection against myeloperoxidase and H202 was also observed with the thioether-containing antibiotics, ticarcillin and ceftazidime, but at higher concentrations than with the aminoglycosides. Analysis of spectral properties, dimethylsulfoxide-mediated reduction, and ethyl acetate/NaCl partitioning, demonstrated that aminoglycosides converted HOCI to hydrophilic noncytotoxic chloramines, but were unable to prevent the oxidation of sulfhydryls and methionine by HOCI. In contrast, ticarcillin and ceftazidime were highly effective inhibitors of HOCI-mediated sulfhydryl and methionine oxidation. These results suggest that aminoglycosides protect lung epithelial cells against myeloperoxidase-dependent oxidant injury by binding to anionic cell surfaces and converting HOCI to hydrophilic noncytotoxic chloramines, whereas penicillins and cephalosporins are potent HOCI scavengers capable of protecting critical extracellular molecules against oxidation. (J. Clin. Invest. 1993.91:3845.) 
Introduction
Chronic inhalation of antibiotics effective against Pseudomonas aeruginosa has been shown to reduce the number of hospital admissions and the rate ofpulmonary function deterioration in patients with cystic fibrosis (CF).' The benefits ofthis therapy are observed despite evidence that Pseudomonas aeruginosa is rarely eradicated from the CF lung and that up to one third of patients receiving inhaled antibiotics develop resistant strains within their bronchial secretions (1) (2) (3) (4) (5) .
Bronchial secretions from CF patients contain bacteria, neutrophils, and their respective toxic products (6) (7) (8) . Both Pseudomonas and activated neutrophils are capable of releasing significant amounts of hydrogen peroxide (H202) (9, 10). In addition, Mohammed et al. ( 11 ) have demonstrated that CF bronchial secretions have high concentrations of myeloperoxidase, a neutrophil-derived enzyme which, in the presence of H202, converts chloride to toxic hypochlorous acid/ hypochlorite anion (HOCl/OCI -', but abbreviated as HOCI for simplicity). These studies suggest that CF airway cells are at risk of oxidant-mediated injury, and that essential molecules at the CF respiratory epithelial surface, such as al-antitrypsin, may undergo oxidative inactivation. In this context, protection of airway epithelial cells and extracellular molecules against HOCl-mediated oxidant damage could conceivably be beneficial to CF patients.
HOCI is a strong oxidant which reacts readily with various chemical groups including primary amines, thiols and thioethers ( 12, 13) . Aminoglycosides, such as gentamicin and tobramycin, have multiple primary amines, whereas ticarcillin and ceftazidime each contain two thioether groups, all ofwhich may potentially react with HOCI ( Fig. 1 ). These antibiotics are among some ofthe anti-Pseudomonas aeruginosa agents most commonly administered intravenously and by aerosolization to CF patients. We hypothesized that, in addition to their microbicidal activity, these antibiotics may have significant antioxidant properties. The present study was designed to determine whether tobramycin, gentamicin, ticarcillin, and ceftazidime can protect lung epithelial cells, methionine, and thiol groups in vitro against myeloperoxidase-derived oxidants.
Methods
Cytotoxicity assay. The cat lung epithelial cell line, AKD (CCL 151; American Type Culture Collection, Rockville, MD) ( 14) was used as the target cell for all cytotoxicity experiments, as previously described ( 15) . The cells were seeded at a density of 50,000 cells per well in 24-well culture plates (Linbro Chemical Co., New Haven, CT) in 0.5 ml of Dulbecco's modified Eagle's medium (DME, Gibco Diagnostic Laboratories, Grand Island, NY) supplemented with 10% calf serum, in 10% CO2 at 37°C. At confluence, the cells were labeled with sodium chromate (5"Cr, 22 formula: cytotoxicity index = (A -B)/(C-B) x 100, whereA isdpm ofthe test sample, B is dpm ofspontaneous release, and Cis dpm of 1% Triton-X-treated cells. Myeloperoxidase and HOCI-induced cytotoxicity. Myeloperoxidase was purified from granulocytes obtained by leukophoresis of a patient with chronic myeloid leukemia, according to the methods of Matheson et al ( 16) . The A430/A2g0 ratio (Reinheit Zahl purity number) of the purified material was 0.82, a value similar to the Reinheit Zahl number of 0.83 reported for 100% pure human myeloperoxidase ( 17) . The labeled cells were incubated with various concentrations (0-5 Ag/ml) of myeloperoxidase for 1 h, followed by the addition of 150 MM H202 to the culture media for 7 h in an atmosphere of 5% CO2 at 37°C. The effect of incubation time of myeloperoxidase before the addition of H202, on cytotoxicity was assessed by adding 2.5 Mig/ml myeloperoxidase to the cells and subsequently adding 150M4M H202 at 0-60 min after the addition of myeloperoxidase. The cells were then incubated for 7 h and the cytotoxicity index determined as described above. Based on the results ofthese experiments, all subsequent experiments were performed using the conditions that induced maximal cytotoxicity, i.e., 2.5 Ag/ml myeloperoxidase added to the media 1 h before the addition of 150 MM H202.
To determine whether cytotoxicity was induced by myeloperoxidase-derived oxidants, cells were incubated with either (a) 2.5 Mg/ml of myeloperoxidase, (b) 150MAM H202, (c) myeloperoxidase + H202, (
heat-inactivated myeloperoxidase (100°C for 10 min) + H202, (e) myeloperoxidase + H202 + 100 U/ml of catalase, (f) myeloperoxi- ,ul was added to the 5'Cr-labeled cells in the absence and presence of200 MM tobramycin, and the final volume was adjusted to 500 Ml with EBSS. The cells were incubated for 1 h, and subsequently either EBSS or 150 AM H202 was added to the media for 7 h at 370C, 5% Co2. The media from the cells was then harvested, centrifuged (500 g, 5 min) and the supernatant was collected to determine the cytotoxicity index. Each condition was evaluated in triplicate.
Thiol and methionine oxidation. To evaluate the capacity of the antibiotics to prevent HOCl-induced oxidation of thiol and methionine, 40,M HOCI was incubated with 0-80,AM gentamicin, tobramycin, ticarcillin, or ceftazidime in EBSS for 15 min at 25°C. Subsequently, either 80 AM 5-thio-2-nitrobenzoic acid, prepared by adding 4 A1 2-mercaptoethanol to 1 mM dithiobis-nitrobenzoic acid as in Thomas et al. (20) , or 100 MM methionine (Sigma Chemical Co., St. Louis, MO) was added to each sample for 15 min at 250C. The residual concentration of 5-thio-2-nitrobenzoic acid was determined by measuring the absorbance of each solution at 412 nm, assuming an ZM = 13,600 (20) .
The ratio of methionine to methionine + methionine sulfoxide was measured immediately after the incubation period by reverse-phase high-pressure liquid chromatography (HPLC), using a modification of the method described by Turnell and Cooper (2 1). Precolumn derivatization was performed by adding 20 Ml sample to 20 Ml o-phthaldialdehyde reagent for 2 min. The o-phthaldialdehyde reagent was composed of 5.5 mg o-phthaldialdehyde dissolved in 1 ml of methanol to which was added 9 ml of 0.5 M potassium borate, pH 9.5, containing 40 Ml of 2-mercaptoethanol. The analytical column was 150 x 4.6 mm i.d. and prepacked with 5 Mm Ultrasphere octadecyl silane (Beckman Instruments Inc., Palo Alto, CA). Solvent A was water and solvent B was methanol. The HPLC apparatus was a Beckman System Gold with a 166 detector set at 340 nm. The gradient, expressed as percentage of solvent B, was brought from 0 to 9% over 1 min, to 11% over 10 min, to 20% over 1 min, held at 20% for 2 min, and brought to 25% over 10 min. Methionine sulfoxide was detected at 8.5 min and methionine at 18.8 min. Subsequently, 60 MM 5-thio-2-nitrobenzoic acid was added to each sample for 15 min at 25°C, and the amount of residual 5-thio-2-nitrobenzoic acid was determined from the absorbance of each sample at 412 nm as described above. All experiments were repeated five times.
The lipophilicity of N-Cl derivatives from the aminoglycoside + HOCI reaction was determined according to the method described by Thomas (22) . Ethyl acetate was treated with 2.64 mM sodium borohydride and 0.1 M NaOH for 30 min to remove contaminating oxidants and acids, and washed extensively with EBSS. Ethyl acetate 3 ml, was added to a 3-ml aqueous sample composed of 200 MM tobramycin or gentamicin and 40 MM HOCI in EBSS. After phase separation, a 2-ml portion of the organic phase was mixed with 2 ml of EBSS, to which was added 400 Ml of 600 MM 5-thio-2-nitrobenzoic acid (sample A). Similarly, 400 Mul of 600 MuM 5-thio-2-nitrobenzoic acid was added to the remaining portion of the combined aqueous and organic phases (sample B). The absorbance of the aqueous portions of each sample was measured at 412 nm and the concentration of oxidizing equivalents was determined using the extinction coefficient zM = 27,200, since one -RNHCI derivative will oxidize two 5-thio-2-nitrobenzoic acid molecules (22) . The concentration of oxidizing equivalents in the organic phase was calculated as 1.5 times that in sample A and the amount in the aqueous phase was calculated as that in sample B minus half that in sample A.
Statistical analysis. All data are expressed as the arithmetic mean±SEM. Analysis of variance was performed using the F test, and the Scheffe test was applied to the data when appropriate (23). A P value < 0.05 was considered significant.
Results
Myeloperoxidase-mediated cytotoxicity. The dose-response assay of myeloperoxidase-induced cytotoxicity to the epithelial cells, in the presence of 150 MM H202, is shown in fig. 2 A. Maximal cytotoxicity was observed at the myeloperoxidase concentration of 2.5 ,g/ml, a concentration used in all subsequent myeloperoxidase-dependent cytotoxicity assays. The effects of preincubation time of myeloperoxidase with the cells before the addition of H202, are shown in Fig. 2 B. When myeloperoxidase was added to the cells simultaneously with H202, the cytotoxicity index was relatively low (cytotoxicity index at 0 min = 12.8 ± 3.3%); however, when myeloperoxidase was allowed to incubate with the cells for various periods oftime before the addition ofH202, a time-dependent enhancement of cytotoxicity was clearly seen (cytotoxicity index at 1 h = 63.0±2.5%, P < 0.001 compared to 0 min). All subsequent experiments were performed with a 1 h preincubation of the cells and myeloperoxidase before the addition of H202.
Evidence that the myeloperoxidase-dependent injury was mediated by oxidants, likely HOCI, is presented in Table I . Neither myeloperoxidase nor H202 alone induced cytotoxicity. However, the co-incubation of both agents consistently induced cytotoxicity. Complete inhibition of cytotoxicity was observed in the presence of catalase (but not heat-inactivated catalase), and in the presence ofheat-inactivated myeloperoxidase, thus further demonstrating the dependence of cytotoxicity on both H202 and myeloperoxidase. Both glutathione, an antioxidant capable scavenging both H202 and HOCI, and methionine, an HOCI scavenger without effect on H202-mediated cytotoxicity, protected the cells, implicating HOCI as the dominant cytotoxic species. Antibiotics prevent myeloperoxidase and HOC/-dependent cytotoxicity. All four antibiotics tested provided a dose-dependent protection ofthe lung epithelial cells against myeloperoxidase/H202-related cytotoxicity ( fig. 3 A) . The antibiotics did not inhibit myeloperoxidase activity (myeloperoxidase alone, 47.1±2.0 U/ml; +tobramycin, 46.3± 1.0 U/ml; +gentamicin, 47.5±1.1 U/ml; +ceftazidime, 45.3±2.0 U/ml; +ticarcillin, 44.6±0.8 U/ml, n = 6, P > 0.05 all comparisons). The most efficient antibiotics were tobramycin and gentamicin, which at 50 MM, decreased the cytotoxicity index from 66.8±3.3% to 0±2% and from 69.6±6.7% to 9.3±8.9%, respectively (P 80 -A.MPO < 0.01, both comparisons). The concentration of tobramycin necessary to provide a reduction of 50% in the cytotoxicity index was consistently 40-50% less than that of gentamicin. Ticarcillin and ceftazidime were also protective but only at much higher concentrations than those ofthe aminoglycosides (200 MM ticarcillin decreased cytotoxicity index from 61.3±5.2% to 27.1±2.4%, 200 MM ceftazidime decreased the cytotoxicity index from 62.8±2.8% to 14.1±1.8%, P < 0.01 both comparisons). In contrast, the protective effects of ticarcillin and ceftazidime against HOCl-induced cytotoxicity were observed within the same concentration range as those of the aminoglycosides ( fig. 3 B) . Tobramycin and CF sputum-H202 cytotoxicity. Sterile-filtered sputum from two CF patients added to the labeled cells at concentrations as high as 250 Ml/ml in EBSS did not induce significant cytotoxicity. H202 alone was not cytotoxic, but in the presence of CF sputum, the cytotoxicity index clearly increased (cytotoxicity index 24% and 37% at 250 ,ul/ml) (Fig.  4) . However, the addition of 200 MM tobramycin to the cells before the addition H202 completely inhibited cytotoxicity at all concentrations of sputum from both patients.
Antibiotic HOCI scavenging properties. HOCl-mediated sulfhydryl oxidation was evidenced by the decrease in 5-thio-2-nitrobenzoic acid concentration from 78.6±0.18 to 26.8±1. 6 MAM in the presence of 40 MM HOC1. Neither tobramycin nor gentamicin prevented 5-thio-2-nitrobenzoic acid oxidation by HOC1 and at 20 gM aminoglycoside, the concentration of 5-thio-2-nitrobenzoic acid was even decreased compared to HOCI alone, an effect attributable to the greater stability of choramines than ofHOC1 (20MuM tobramycin + HOC1, 5-thio-2-nitrobenzoic acid = 17.6±0.1 MM; 20 MM gentamicin + HOCI, 5-thio-2-nitrobenzoic acid = 18.8±0.1 MM, P < 0.01, both compared to HOCI alone) (Fig. 5 A) . An opposite effect was observed when either ticarcillin or ceftazidime was added to HOC1 in the presence of 5-thio-2-nitrobenzoic acid, with marked protection against thiol oxidation (25 MM ticarcillin + HOCI, 5-thio-2-nitrobenzoic acid = 70.0±2.6 MM; 20 IM ceftazidime + HOC1, 5-thio-2-nitrobenzoic acid = 69.4±0.1 MM, P < 0.001 compared to HOC1 alone).
Similarly, ticarcillin and ceftazidime, at concentrations of < 10 MM efficiently protected methionine from HOCI-dependent oxidation, whereas both tobramycin and gentamicin, even at concentrations as high as 40 MM, were unable to completely block the formation ofmethionine sulfoxide (Fig. 5 B) . Characterization of the HOCI-aminoglycoside reaction product. The maximal absorbance of HOCI alone was observed at a wavelength of291 nm (Fig. 6) . However, in the presence of either tobramycin or gentamicin, the maximal absorbance was shifted to a wavelength of 252 nm, as expected of chloramines derived from primary amines (20) . Consistent with the knowledge that gentamicin has fewer primary amine groups than tobramycin (Fig. 1) , the maximal absorbance at 252 nm ofthe gentamicin-HOCl solution was always lower than that of the tobramycin-HOCl solution.
Further evidence that chloramines were formed from the reaction of aminoglycosides and HOCI is shown in Fig. 7 . Neither tobramycin nor gentamicin alone affected the 5-thio-2-nitrobenzoic acid concentration in a buffered solution (5-thio-2-nitrobenzoic acid alone = 63.2±0.1 ,uM, + tobramycin = 62.4±0.2,iM, + gentamicin = 62.6±0.2, P > 0.05 all comparisons). As Partitioning of the aminoglycoside-HOCl reaction products between the organic and aqueous phases of an ethyl acetate/NaCl gradient revealed that nearly all of the oxidizing equivalents mobilized to the aqueous phase, thus confirming the hydrophilic nature of the oxidant products (Table II) .
Discussion
Epithelial cells of the upper and lower respiratory tract are exposed to high concentrations of extracellular myeloperoxidase in diseases such as the adult respiratory distress syndrome (ARDS), idiopathic pulmonary fibrosis (IPF), and CF (11, 18, 24) . The presence of oxidized a,-antitrypsin and of methionine sulfoxide in the bronchoalveolar lavage fluid of patients with ARDS and IPF, respectively, provides direct evidence of an excessive oxidant burden in vivo (24, 25) . Furthermore, a,-antitrypsyin is inactive in the airway secretions of CF patients, an observation that may, at least in part, be explained by a high oxidant burden (7, 26) . The present study documents that the aminoglycosides, ticarcillin and ceftazidime, all efficient anti-Pseudomonas aeruginosa antibiotics commonly used in the treatment of CF lung infections, have cytoprotec- Myeloperoxidase and H202 added simultaneously to the lung epithelial cells caused little cytotoxicity, and it was found necessary to preincubate myeloperoxidase with the cells before the addition of H202 to induce maximal cytotoxicity. Myeloperoxidase is a highly cationic enzyme at physiologic pH, with a pl > 10 (27) . Based on studies of myeloperoxidase-mediated glomerular injury, it has been suggested that myeloperoxidase, bound to anionic sites, reacts with H202 to induce epithelial cell cytotoxicity (28) . The presence of anionic sites, particularly negatively charged phospholipids (29) , in the membranes of normal epithelial cells raises the possibility that binding of myeloperoxidase to the epithelial cell surface through charge interaction is necessary to induce maximal cytotoxicity.
It is of interest that although the four antibiotics tested in the present study were of equivalent efficacy in preventing HOCl-induced cytotoxicity, the aminoglycosides were approximately fivefold more efficient than either ticarcillin or ceftazidime in preventing myeloperoxidase-mediated injury. None of the antibiotics were found to inhibit myeloperoxidase activity. Because ofthe cationic nature ofthe aminoglycosides (30) , the likely explanation for this discrepancy is that the aminoglycosides bound to anionic cell surfaces as did myeloperoxidase and thus reacted with HOCI at its site ofsynthesis. In contrast, both ceftazidime and ticarcillin are organic anions at physiologic pH (31) . Although ticarcillin and ceftazidime are potent HOCI scavengers, charge interactions may keep them away from areas of myeloperoxidase-dependent HOC1 synthesis at anionic sites of the cell surface.
The mechanisms by which the aminoglycosides and the thioether-containing antibiotics, ticarcillin and ceftazidime, protected epithelial cells were different. Several lines of evidence suggest that the HOCI-aminoglycoside reaction resulted in the formation of chloramines. First, the reaction product was capable of oxidizing the thiol group of 5-thio-2-nitrobenzoic acid, as would be expected of chloramines (32, 33) . Second, both aminoglycosides shifted the maximal absorbance wavelength of HOC1 from 291 to 252 nm, a characteristic absorption peak for chloramines derived from primary amines (20) . Third, whereas DMSO can reduce HOCI, it is unable to reduce chloramines (20) . Because DMSO could reduce HOCI alone but not in the presence of either aminoglycoside, these results further support the conclusion that chloramines were synthesized.
Chloramines, while retaining oxidant properties can be either cytotoxic or noncytotoxic, depending, in part, on their relative lipophilicity (32) . In that the cell membrane is com-posed primarily of lipids, the lipophilic chloramines are generally more cytotoxic than the hydrophilic ones. Consistent with the polar, hydrophilic properties of aminoglycosides (34) , the present studies indicate that the aminoglycoside-HOCl chloramines were mostly hydrophilic, a characteristic that likely contributed to render the aminoglycoside/HOCl product innocuous. Since all aminoglycosides are rich in primary amines, other antibiotics of this class may have similar cytoprotective properties, but would not be expected to protect extracellular sulfhydryl and methionine groups against HOCl-mediated oxidation.
Although the thioether-containing antibiotics were less efficient than aminoglycosides at protecting lung epithelial cells against myeloperoxidase-mediated injury, they were much more effective in preventing HOCl-mediated oxidation of sulfhydryl groups and methionine. The anti-HOCl properties of ticarcillin and ceftazidime were identical in all assays, suggesting that similar mechanisms, such as thioether-mediated reduction of HOCI, may have been involved for each antibiotic. These observations likely apply to many other penicillins and cephalosporins, all of which contain thioether groups in their thiazolidine and dihydrothiazine rings (35) . It is of interest that the protection of methionine against oxidation has been shown to prevent the inactivation of the major anti-elastase protein, a,-antitrypsin (36 (39) (40) (41) . However the observations from the present study differ in that they demonstrate the capacity of anti-Pseudomonas aeruginosa antibiotics to react with HOCI at a rate sufficient to protect lung epithelial cells and, for the thioethercontaining antibiotics, thiol groups and methionine from myeloperoxidase-dependent oxidation. These properties may be of particular interest in the therapy of CF lung disease, and of other infectious diseases of the lung, an organ which has an unexpected sensitivity to damage from HOCl-derived oxidants (33).
The epithelial lining fluid of the normal lung contains many molecules that could potentially react with HOCI and act as endogenous antioxidants ( 15) . If these naturally occuring antioxidants were always sufficient to prevent oxidation of essential lung molecules and epithelial cell death, then the antioxidant properties of antibiotics would be irrelevent. Evidence from the literature, such as methionine oxidation in IPF, and a,-antitrypsin oxidation in ARDS, suggests that the lung's naturally occuring antioxidants are not always sufficient to prevent oxidative damage and can be overwhelmed in neutrophilic inflammatory diseases (24, 25) . These data would thus support the concept that antibiotic antioxidant properties may be clinically relevent. However, the current study does not confirm in vivo antioxidant efficacy, and further studies are needed.
The potential usefulness of these various classes of antibiotics as antioxidants may be modulated by several factors. First, significant antioxidant properties were observed at antibiotic concentrations of 2 25 1M. These relatively high concentrations may be difficult to maintain in tissues involved in purulent infections. Second, although aerosolization of large doses of antibiotics to the respiratory tract in CF is safe and may be a rational approach to maintain high concentrations of antibiotics in the airways ( 1-5), it is not clear that the antibiotics will reach the epithelial surface in areas of severe inflammation. Aerosol distribution in the CF lung has been shown to be less efficient in patients with more severe lung disease (42) . However, the current study raises the question of whether efficient delivery of aerosolized antibiotics to the young CF patient, before severe airway damage has occurred, could significantly delay destructive lung disease by providing effective antioxidant protection. Third, the potential problem ofselecting resistant bacteria by routinely administering aerosolized antibiotics for their antioxidant properties must be considered. While this is an important consideration, experience with aerosolized antibiotics in CF to date, would indicate that resistance has not prevented this form oftherapy from providing definite benefits to selected CF patients (1) (2) (3) (4) (5) . Finally, inhibition ofthe toxicity of the myeloperoxidase system may decrease the bactericidal activity of neutrophils (37) . However, this may not be a major problem, because (a) patients with a hereditary deficiency of myeloperoxidase are only slightly more susceptible to bacterial infections than are normal subjects (43), (b) CF patients receiving aerosolized antibiotics do not demonstrate more severe lung infections (1) (2) (3) (4) (5) , and (c) the major pathogenic bacteria in the CF lung, the mucoid Pseudomonas aeruginosa, is already protected against myeloperoxidase-derived oxidants by an alginate coat that efficiently scavenges HOCI (44) . Indeed, one may speculate that, ifthe mucoid Pseudomonas aeruginosa has adapted to its HOCl-rich environment by protecting itself against HOCl, then the CF airways may also benefit from anti-HOCI protection.
In summary, aminoglycosides convert HOCI to noncytotoxic chloramines and protect lung epithelial cells against myeloperoxidase-mediated oxidant injury. Thioether containing antibiotics, specifically ticarcillin and ceftazidime, but likely many other penicillins and cephalosporins, are potent HOCI scavengers and protect lung epithelial cells, sulfhydryl groups, and methionine from HOCI-mediated oxidation. These antioxidant properties of antibiotics may contribute to the protection of tissues involved in purulent infections, particularly the lung in patients with CF.
